CollPlant Biotechnologies Ltd Cost of Revenue
CollPlant Biotechnologies Ltd (CLGN) reported Cost of Revenue of $835.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-03-26
- CollPlant Biotechnologies Ltd cost of revenue for the quarter ending 2025-06-30 was $186.00K, a 65.30% decline year-over-year.
- CollPlant Biotechnologies Ltd cost of revenue for the quarter ending 2024-06-30 was $536.00K, a 12.85% decline year-over-year.
- CollPlant Biotechnologies Ltd cost of revenue for the quarter ending 2023-06-30 was $615.00K, a 1330.23% increase year-over-year.
- CollPlant Biotechnologies Ltd cost of revenue for the quarter ending 2022-06-30 was $43.00K, a 89.98% decline year-over-year.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|---|
| 2025-12-31 | $835.00K 20-F · filed 2026-03-26 | ||
| 2025-06-30 | $186.00K 6-K · filed 2025-08-20 | $374.00K 6-K · filed 2025-08-20 | |
| 2024-12-31 | $1.63M 20-F · filed 2026-03-26 | ||
| 2024-06-30 | $536.00K 6-K · filed 2025-08-20 | $1.08M 6-K · filed 2025-08-20 | |
| 2023-12-31 | $1.99M 20-F · filed 2026-03-26 | ||
| 2023-06-30 | $615.00K 6-K · filed 2024-08-20 | $940.00K 6-K · filed 2024-08-20 | |
| 2022-12-31 | $400.00K 20-F · filed 2025-03-26 | ||
| 2022-06-30 | $43.00K 6-K · filed 2023-08-24 | $74.00K 6-K · filed 2023-08-24 | |
| 2021-12-31 | $2.00M 20-F · filed 2024-04-04 | ||
| 2021-06-30 | $429.00K 6-K · filed 2022-08-25 | $1.31M 6-K · filed 2022-08-25 | |
| 2020-12-31 | $3.00M 20-F · filed 2023-03-29 | ||
| 2020-06-30 | $748.00K 6-K · filed 2021-08-19 | $1.22M 6-K · filed 2021-08-19 | |
| 2019-12-31 | $1.88M 20-F · filed 2022-03-24 | ||
| 2019-06-30 | $463.00K 6-K · filed 2020-08-28 | $883.00K 6-K · filed 2020-08-28 | |
| 2018-12-31 | $1.66M 20-F · filed 2021-03-26 |